Top Markets
Coin of the day
Asarina Pharma AB (publ) Asarina Pharma AB (publ)

Asarina Pharma AB (publ)

ASAP
株式のランク #40862
Asarina Pharma AB (publ) is a biotech enterprise, specializing in the research... Asarina Pharma AB (publ) is a biotech enterprise, specializing in the research and development of pharmaceutical products. Their key therapeutic agent, Sepranolone, is developed to address menstrual migraine and Tourette syndrome. Founded in 2005, this Solna, Sweden-based company was previously known as Umecrine Mood AB before officially changing its name to Asarina Pharma AB (publ) in 2016.
株価
$0.00312742
最終同期: 2024-10-01
時価総額
$70.81K
変化(1日)
-21.83%
変化(1年)
0.00%
SE
取引 Asarina Pharma AB (publ) (ASAP)

カテゴリー

Asarina Pharma AB (publ)(ASAP)のP/B比率
August 2026 時点のP/B比率 TTM: 0.38
Asarina Pharma AB (publ) の最新の財務報告および株価によると、現在のP/B比率(TTM)は 0.38 です。2022 年末時点でのP/B比率は 1.20 でした。
Asarina Pharma AB (publ) の P/B 比率の履歴(2017 ~ 2026)
各年末時点のP/B比率
P/B比率 変化
2026 (TTM) 0.38 -96.82%
2023 12.08 910.92%
2022 1.20 -30.43%
2021 1.72 -20.01%
2020 2.15 -36.68%
2019 3.39 20.78%
2018 2.81 -89.55%
2017 26.87 0.00%
同業他社のP/B比率
企業 P/B比率 P/B比率の差
6.2613 1,528.85%
US
6.3483 1,551.48%
NL
- -
CH
- -
KR
3.634 845.37%
BE